FIELD: medicine.
SUBSTANCE: invention relates to nutritive therapy and is intended for treatment and/or prevention of delayed recall function impairment in subjects who have 24-26 points by Mini-mental State Examination (MMSE). Claimed is application of composition for obtaining product for enteral introduction. Composition contains uridine or uridine phosphate, docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA), phospholipids, choline, vitamin E, vitamin C, selenium, vitamin B12, vitamin B6 and folic acid.
EFFECT: claimed invention provides improvement of memory, in particular, delayed recall function, in patients with 24-26 points by MMSE.
5 cl, 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
IMPROVEMENT OF MEMORY IN PATIENTS WITH ESTIMATION OF 24-26 POINTS OF MINIMAL MENTAL STATE EXAMINATION | 2014 |
|
RU2677345C2 |
METHOD FOR IMPROVING FUNCTIONAL SYNAPTIC CONNECTIVITY | 2013 |
|
RU2667968C2 |
RECOGNITION IMPROVEMENT | 2012 |
|
RU2638809C2 |
NUTRITIVE PRODUCT FOR REDUCING PHENYLALANINE LEVELS IN THE PATIENTS WITH PKU | 2016 |
|
RU2740905C2 |
NUTRITIONAL COMPOSITION FOR IMPROVING CEREBRAL FUNCTION IN PHENYLKETONURIA | 2014 |
|
RU2690660C2 |
METHOD FOR CONTROL FUNCTIONS IMPROVEMENT | 2012 |
|
RU2637089C2 |
METHOD FOR ASSESSING AND TREATING OR PREVENTING DISTURBED LEVELS OF POLAR LIPIDS IN PLASMA | 2015 |
|
RU2705208C2 |
COMBINATION OF COMPONENTS FOR PREVENTION AND TREATMENT OF INDISPOSITION | 2011 |
|
RU2646830C2 |
NON-MEDICAL INCREASE OR MAINTENANCE OF BODY WEIGHT OF A MAMMAL | 2011 |
|
RU2647461C2 |
FOOD COMPOSITION FOR PATIENTS SUFFERING FROM PRODROMAL DEMENTIA | 2008 |
|
RU2487557C2 |
Authors
Dates
2014-09-27—Published
2008-06-20—Filed